Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18-Reference-Cited by-同舟云学术

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18

Published:2016-03-14 Issue:9 Volume:173 Page:1407-1424
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Carvalho Silvia¹,Levi-Schaffer Francesca²,Sela Michael³,Yarden Yosef¹

Affiliation:

1. Department of Biological Regulation; Weizmann Institute of Science; Rehovot Israel

2. Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine; The Hebrew University of Jerusalem; Jerusalem Israel

3. Department of Immunology; Weizmann Institute of Science; Rehovot Israel

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13450/fullpdf

Reference191 articles.

1. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases;Abella;Am J Physiol Endocrinol Metab,2009

2. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice;Aboud-Pirak;J Natl Cancer Inst,1988

3. The Concise Guide to PHARMACOLOGY 2015/16: Overview;Alexander;Br J Pharmacol,2015a

4. The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors;Alexander;Br J Pharmacol,2015b

5. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors;European Journal of Pharmacology;2024-05

2. Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators;Cancers;2023-10-16

3. Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging;Biomedicines;2023-07-24

4. Receptor tyrosine kinase inhibitors in cancer;Cellular and Molecular Life Sciences;2023-03-22

5. Immune Checkpoint Glycoproteins Have Polymorphism: Are Monoclonal Antibodies Too Specific?;Current Oncology;2023-01-16